Public Pathology Australia (and its predecessor, the National Coalition of Public Pathology) makes submissions to inquiries and reviews by governments and other bodies that affect public pathology as part of our advocacy activities.

Public Pathology Australia submissions include:

Future of Pathology
Public Pathology – Value and Opportunities

Australian Competition and Consumer Commission (ACCC) and Productivity Commission on competition (Competitive Neutrality Policy Review)

Federal Department of Health on funding under the Medicare Benefits Schedule (MBS), on applications to the Medical Services Advisory Committee (MSAC) for listing of items onto the MBS,  on strengthening the provisions of the Health Insurance Act 1973  and other matters as outlined below.

Public Pathology’s Response to COVID-19
Health Technology Assessment Review
National Health Reform Agreement and the Mid Term Review
Australian Centre for Disease Control, Dec 2022
COVID MBS items, Aug 2021
MBS Review – Pathology, Nov 2018
MBS Review – Pathology Endocrine Tests Oct 2017
MBS Review, Nov 2015
Impact of Cervical Screening Changes, Apr 2015
Managing MBS Outlays, Jan 2015
Funding Parity Business Case

Federal Treasury
2023/24 Pre-Budget Submission
2021/22 Pre-Budget Submission
2020/21 Pre-Budget Submission
2019 Pre-Budget Submission
2018/19 Pre-Budget Submission
2017 Pre-Budget Submission

National Pathology Accreditation Advisory Council (NPAAC) on laboratory standards and requirements.

Submission on the NPAAC Requirements for Information Communication and Reporting Jan 2020
Submission on the NPAAC Requirements for the Communication of High Risk Pathology Results (1st edition 20XX) Jan 2020
Submission on the NPAAC Requirements for Point of Care Testing (2nd Edition) Jan 2020
Submission on the NPAAC Requirements for Laboratories reporting tests for the National Cervical Screening Program (2nd edition) Dec 2018
Submission on the NPAAC Requirements for Validation of Self-Collected Vaginal Swabs for Use in the National Cervical Screening Program Dec 2018
Submission on the NPAAC Requirements for Transfusion Laboratory Practice Fourth Edition 2018 Dec 2018
Submission on the NPAAC Requirements For The Clinical Governance And Supervision Of Medical Pathology Laboratories Submission Nov 2016
Submission on the NPAAC Requirements for Laboratories Reporting Cervical Screening Submission Nov 2016
Submission on the NPAAC Communications Submission Aug 2015

Public Pathology Australia
Position Against Discrimination, Bullying and Sexual Harassment

Therapeutic Goods Administration
Submission on the Proposal for the Regulation of IVD Companion Diagnostics Dec 2018

Senate Committees– such as the Community Affairs Committee on Gene Patents, a National Registration and Pathology Request Form Changes to give consumers greater choice of pathology provider and to the Legislative and Constitutional Committee on the Patent Amendment (Human Genes and Biological Materials) Bill 2010.

Other submissions have been made on the:
National Cancer Screening Register Bill 2016
National Cancer Screening Register (Consequential and Transitional Provisions) Bill 2016 Submission Sept 2016
Senate Inquiry National Cancer Screening Register

State Matters
Submission on Victoria’s response to the Pandemic
Submission to the Victorian Government about Victoria’s response to COVID-19 Nov 2020
Submission to the Select Committee into Matters Relating to SA Pathology Feb 2019
Submission on the Victorian Public Pathology Plan Oct 2017
Submission on SA Pathology Review, Feb 2015